Ireland· IE-PA-PA2238/001/001
Methocarbamol 750 mg film-coated tablets
A methocarbamol product containing methocarbamol, registered in Ireland by HBS Healthcare. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Methocarbamol is registered in 12 of 19 countries.
Countries holding a registration under ATC M03BA03 (methocarbamol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Methocarbamol · ATC M03BA03
12 / 19 countries
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of methocarbamol costs, country by country.
Normalised to the WHO defined daily dose (3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methocarbamol · price per daily dose (3 g)
USD · FX 28 Sept 2026
- US United States$0.17 (acquisition cost)
The record
At a glance
HPRA (Ireland)- Active substance
- Methocarbamol
- Manufacturer
- HBS Healthcare
- Country
- Ireland (IE)
- ATC code
- M03BA03
- ATC class
- Methocarbamol
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2238/001/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
169 interactions on record for methocarbamol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methocarbamol · interactions on record
169 records
- 4 severe
- 53 moderate
- 112 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methocarbamol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethocarbamolSportpharm LLC
- SwitzerlandMetoflex 750 mg, comprimés pelliculésLabatec Pharma SA
- SpainMOLITREM 750 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNeuraxpharm Spain S.L.
- NorwayMethocarbamol alAliud Pharma
- United KingdomMethocarbamol 1500mg tabletsAlliance Healthcare (Distribution) Ltd
- GermanyMethocaPuren Pharma Gmbh & Co. Kg
- CzechiaDOLIROBAXGOODWILL PHARMA Plc., Szeged
- FranceLUMIRELAX 10 %, crèmeLABORATOIRES JUVISE PHARMACEUTICALS
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Austria · Methocarbamol Kwizda
- Czechia · Dolirobax
- Germany · Methoca, Methocarbamol Al
- Spain · Dolirobax, Molitrem
- France · Lumirelax, Methocarbamol Arrow
- United Kingdom (Northern Ireland) · Methocarbamol Activase Pharmaceuticals, Methocarbamol Amarox
- Hungary · Dolirobax Tabletta
- Luxembourg · Methocarbamol Micro Labs
- Malta · Rolaxifor
- Poland · Methocarbamol Espefa
- Portugal · Robaxisal, Zelaz
- Slovakia · Dolirobax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/de153c4e-66e8-46da-9a60-f1d6e8d0c90c GET /v1/drugs/de153c4e-66e8-46da-9a60-f1d6e8d0c90c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"M03BA",
"M03BA03"
],
"strength": null,
"pa_number": "PA2238/001/001",
"substances": [
"Methocarbamol"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "01/11/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about methocarbamol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.